why choose us

Clinical Trials Search

Showing 17,830 of 132,963 result(s)
Impact of a PERsonalized CAse MAnagement Program for the Follow-up of Moderate and Severe aSTHma Patients on Exacerbations, Health Resource Use and Asthma Control: PERCASTHMA STUDY

Status: COMPLETED

Condition: Asthma

Interventions: The case manager will monitor asthma control (asthma control test, ACT) and adherence to treatment with questionnaires (inhaler adherence test, TAI) a

Date: 2022-11-30

Mulligan Mobilization in Rheumatoid Hand

Status: COMPLETED

Condition: Rheumatoid Arthritis

Interventions: Mobilization with movement (MWM) is the concurrent application of sustained accessory mobilization applied by a therapist and an active physiological

Date: 2022-11-30

The Influence of Demographic Parameters and ACL Injury on the Association Among Clinical, Functional and Biomechanical Parameters

Status: COMPLETED

Condition: Anterior Cruciate Ligament (ACL) Injury

Interventions: Analysis of existing data from previous research projects MechSens (EKNZ 2019-01315) and RetroBRACE I and II (EKNZ 2019-00491 and EKNZ 2020-00551) as

Date: 2022-11-30

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

Status: COMPLETED

Condition: COVID-19, SARS-CoV-2

Interventions:

600 mg AZD5156 consisting of 300 mg AZD1061 at 100 mg;mL and 300 mg AZD3152 at 150 mg;mL

3 mL of AZD1061 2 mL of AZD3152 IM on Visi

Date: 2022-11-30

General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery

Status: COMPLETED

Condition: Elective Surgery

Interventions:

Octenidin body lotion once a day during the five consecutive days preceding the elective orthopedic surgery, including for the hair.

Octenidi

Date: 2022-11-30

A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus

Status: COMPLETED

Condition: Invasive Candidiasis

Interventions: Intravenous injection (IV), once a day after reaching the recommended dose of 3.0-4.0
mg;kg for treatment.
Subjects will receive ABCD i

Date: 2022-11-29

A Study for Observing Severe Asthma in Patients Treated With Tezepelumab

Status: COMPLETED

Condition: Asthma

Interventions: Not applicable since it's an observational study.

Date: 2022-11-29

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Status: COMPLETED

Condition: Actinic Keratoses

Interventions: COMBINATION_PRODUCT: BF-200 ALA and red light LED lamp - Up to two PDTs using a RhodoLED lamp (RhodoLED® XL or BF-RhodoLED®) (ALA-PDT, Ameluz®-PDT):

Date: 2022-11-29

Virtual Visits for Postoperative Care Following Urogynecologic Surgery

Status: ACTIVE_NOT_RECRUITING

Condition: Satisfaction, Patient

Interventions: Patients randomized to this arm will be scheduled for and follow up with the surgeon or an advanced practice provider via a virtual visit using videoc

Date: 2022-11-29